GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.1656
-0.0192 (-10.39%)
At close: Jan 9, 2026, 4:00 PM EST
0.1658
+0.0002 (0.12%)
After-hours: Jan 9, 2026, 7:49 PM EST
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $7.11 million as of January 9, 2026. Its market cap has decreased by -67.08% in one year.
Market Cap
7.11M
Enterprise Value
2.38M
1-Year Change
-67.08%
Ranking
Category
Stock Price
$0.17
Market Cap Chart
Since May 13, 2019, GeoVax Labs's market cap has increased from $1.04M to $7.11M, an increase of 581.29%. That is a compound annual growth rate of 33.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 7.94M | 8.07% |
| Dec 31, 2025 | 7.34M | -68.49% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.12B |
| UnitedHealth Group | 314.19B |
| AstraZeneca | 295.31B |
| Merck & Co. | 275.48B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |